CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Incontinence - urinary, in women - Management
What advice should I give to someone prescribed intravaginal oestrogen?
- Advise the woman that:
- Topical oestrogens should be used in the lowest effective dose to minimize systemic absorption.
- Medical advice should be sought if she experiences breakthrough bleeding or spotting at any time during treatment (see Adverse effects).
- Warn the woman that certain intravaginal oestrogen preparations can damage latex condoms and diaphragms (for example Ortho-Gynest® cream and pessaries, and Ovestin® cream).
- If in doubt, check the Summaries of Product Characteristics (SPCs) or the patient information leaflets.
© NHS Institute for Innovation and Improvement